Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Dolatshahi

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|May 8, 2019
Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesiaShayan Pourmirbabaei, Mahsa Dolatshahi, Farzaneh Rahmani
Molecular Neurobiology|January 27, 2021
Correction to: Pathophysiological Clues to how the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to NeurodegenerationMahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Molecular Neurobiology|January 8, 2021
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to NeurodegenerationMahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Reviews in the Neurosciences|May 28, 2018
Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapyGhazaleh Kheiri, Mahsa Dolatshahi, Farzaneh Rahmani, et al.
The European Journal of Neuroscience|March 14, 2021
Mitigating the negative impacts of aging on cognitive function; modifiable factors associated with increasing cognitive reserveMobina Amanollahi, Saba Amanollahi, Ali Anjomshoa, et al.
Brain Research|April 19, 2019
Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic optionsSoheil Mohammadi, Mahsa Dolatshahi, Ameneh Zare-Shahabadi, et al.
Neuroimaging Clinics of North America|April 10, 2025
Altered Clearance in Alzheimer's Disease and Cerebral Amyloid AngiopathySoheil Mohammadi, Mahsa Dolatshahi, Farzaneh Rahmani, et al.
The European Journal of Neuroscience|April 22, 2021
Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegenerationMahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSara KamaliZonouzi, Mobina Amanollahi, Mahsa Dolatshahi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2018
Association of olfaction dysfunction with brain microstructure in prodromal Parkinson diseaseHossein Sanjari Moghaddam, Mahsa Dolatshahi, Elaheh Salardini, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|May 8, 2019
Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesiaShayan Pourmirbabaei, Mahsa Dolatshahi, Farzaneh Rahmani
Molecular Neurobiology|January 27, 2021
Correction to: Pathophysiological Clues to how the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to NeurodegenerationMahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Molecular Neurobiology|January 8, 2021
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to NeurodegenerationMahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Reviews in the Neurosciences|May 28, 2018
Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapyGhazaleh Kheiri, Mahsa Dolatshahi, Farzaneh Rahmani, et al.
The European Journal of Neuroscience|March 14, 2021
Mitigating the negative impacts of aging on cognitive function; modifiable factors associated with increasing cognitive reserveMobina Amanollahi, Saba Amanollahi, Ali Anjomshoa, et al.
Brain Research|April 19, 2019
Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic optionsSoheil Mohammadi, Mahsa Dolatshahi, Ameneh Zare-Shahabadi, et al.
Neuroimaging Clinics of North America|April 10, 2025
Altered Clearance in Alzheimer's Disease and Cerebral Amyloid AngiopathySoheil Mohammadi, Mahsa Dolatshahi, Farzaneh Rahmani, et al.
The European Journal of Neuroscience|April 22, 2021
Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegenerationMahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSara KamaliZonouzi, Mobina Amanollahi, Mahsa Dolatshahi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2018
Association of olfaction dysfunction with brain microstructure in prodromal Parkinson diseaseHossein Sanjari Moghaddam, Mahsa Dolatshahi, Elaheh Salardini, et al.
Pageof 6